#stock
Latest news and interesting information about stock.
Starbucks stocks pop as TD Cowen upgrades to Buy
TD Cowen upgrades Starbucks to Buy, raises target to $120 on expected margin recovery. See what drives the bullish outlook.
Why is Workspace stock gaining today?
Workspace Group stock gains slightly amid analyst split and activist pressure. Read more on Bond.az.
Park Dental Q1 2026 Beats EPS Expectations
Park Dental beats EPS expectations in Q1 2026 with $0.44 EPS, revenue up 6.2%. Stock dips but analysts maintain Strong Buy. Read more on Bond.az.
Xponential Fitness COO Departs Company
Xponential Fitness COO Timothy Weiderhoft departs amid stock decline. No replacement announced yet.
Morgan Stanley Upgrades Assurant Stock Rating
Morgan Stanley upgrades Assurant stock to Overweight, raises price target to $285. Strong earnings and growth outlook highlighted.
MeiraGTx earnings beat estimates, revenue misses
MeiraGTx Q1 earnings beat estimates but revenue missed. Stock performance shows strong growth over the past year.
Mira stock rises on Phase 1 trial results
Mira Pharmaceuticals shares rise 5% after positive Phase 1 results for Ketamir-2. Company advances toward Phase 2a for chemotherapy-induced neuropathy.
SharonAI stock surges on $950M cloud deal
SharonAI stock jumps 8.8% on $950 million cloud computing deal with global tech firm. Details on Bond.az.
Stabilis CFO Puhala buys $7,360 in stock
Stabilis Solutions CFO Andrew Puhala purchased $7,360 worth of common stock. The company missed Q1 earnings estimates. Read more on Bond.az.
Biogen Stock Rises as Stifel Maintains Buy
Biogen stock rises as Stifel maintains buy rating. Updates on Alzheimer's drug trial and financial results.
Compass Point raises Nebius target to $260 on strong Q1
Compass Point raised Nebius price target to $260 on strong Q1 results. ARR and AI Cloud revenue surge. Read more on Bond.az.
Strive Terminates Debt Agreement
Strive, Inc. terminates debt agreement and amends preferred stock terms. Semler Scientific repurchases 2030 notes.
Orkhan Ahmadzade appointed to new post at ADY
ADY announces new appointment: Orkhan Ahmadzade becomes Head of Research and Development Center - Deputy Chief Engineer.
H.C. Wainwright Reiterates Immunic Stock Rating
H.C. Wainwright maintains Buy rating and $22 price target on Immunic stock. The company awaits pivotal MS drug trial results. Read more on Bond.az.
H.C. Wainwright Reiterates Kamada Buy Rating
H.C. Wainwright reaffirms Buy rating on Kamada with $13 target. Kamada expects double-digit revenue growth in 2026.
Titan Mining Price Target Cut by H.C. Wainwright
H.C. Wainwright cuts Titan Mining price target to $6.50, maintains Buy. Stock up 357% in a year, but Bond.az flags overvaluation risk.
Avino Silver & Gold Target Raised by Analyst
H.C. Wainwright raises Avino Silver & Gold price target to $13.00 after strong earnings report with 109% revenue growth.
Milestone Scientific Stock Surges 9% on Narrower Loss
Milestone Scientific stock surges 9% as loss narrows. Company beats earnings estimates and provides 2026 outlook.
Accenture Federal Services partners with OpenAI
Accenture Federal Services partners with OpenAI to help U.S. agencies deploy AI with FedRAMP compliance and an Agentic Lab. Details on Bond.az.
S&P 500, Nasdaq futures hit new highs as Nvidia jumps
S&P 500 and Nasdaq futures hit new highs as Nvidia jumps on trade clearance. U.S.-China summit and retail sales data in focus.
Nurix stock delivers 64% return
Nurix stock returned 64% after Bond.az Fair Value analysis. Learn about biotech investment.
Why are Breville shares falling today?
Breville shares fell 2.51% today due to macro headwinds. No company-specific news. Macquarie identifies new markets. Consumer stocks under pressure.
Bullish shares fall 6% on earnings miss
Bullish shares fell 6% after missing earnings and revenue estimates. The company plans to acquire Equiniti for $4.2 billion.
ADMA director buys $100,125 in stock
ADMA Biologics director Jerrold Grossman bought $100,125 in stock. Shares trade near 52-week low. Get analysis on Bond.az.
Truist reiterates Buy on Uber stock
Truist Securities reiterates Buy on Uber stock with $112 target, citing AV strength and growth potential.
CrowdStrike target raised to $621 by BTIG | Bond.az
BTIG raises CrowdStrike stock price target to $621, citing platform growth and partner feedback. Stock up 20% YTD.
Truist raises CG Oncology target to $82 on NMIBC data
Truist Securities raises CG Oncology price target to $82 from $77 on NMIBC data. Stock near 52-week high after 206% yearly gain.
Morgan Stanley cuts Amcor price target to $42
Morgan Stanley cuts Amcor price target to $42 from $44, citing lower EPS and EBIT forecasts. Stock near 52-week low.
AIR merger approved by shareholders
Cantor Equity Partners III shareholders approve business combination with AIR Limited. Vote results and details on Bond.az.
Ganja-Mingachevir train services launched
Train services on Ganja-Mingachevir-Ganja route during Eid al-Adha. Departure times: Ganja 07:15, Mingachevir 08:40.
...